title: What do we know about direct-to-consumer advertising of prescription drugs?
abstract: Two papers, by Joel Weissman and colleagues and by Robert Dubois, add to our limited knowledge of the effects of direct-to-consumer (DTC) advertising of prescription drugs. Their results reinforce the largely positive findings from consumer surveys, while adding valuable new data and insights. These suggest that DTC ads probably improve patients' health outcomes and do not tend to lead to inappropriate prescribing. DTC advertising is emerging as a positive force in health care markets, consistent with what is known about the effects of advertising in many other markets.
authors.affiliation: American Enterprise Institute, Washington, DC, USA.
authors.forename: John E
authors.initials: JE
authors.lastname: Calfee
mesh_terms: D000329:Advertising; D004345:Drug Industry; D004363:Drug Utilization; D005069:Evaluation Studies as Topic; D019538:Health Care Surveys; D006801:Humans; D010358:Patient Participation; D010817:Physician-Patient Relations; D010818:Practice Patterns, Physicians'; D014481:United States